India, Feb. 6 -- A landmark clinical trial has demonstrated that artificial intelligence can dramatically improve breast cancer screening, achieving a 29% increase in early cancer detection while reducing radiologists' workload by nearly half - findings that could transform how mammograms are evaluated worldwide and underscore the potential of machine learning. The randomised controlled study, published on Tuesday in The Lancet Digital Health, evaluated over 105,000 women in Sweden between April 2021 and December 2022, making it the largest and most comprehensive trial of AI in mammography screening to date.P12...